FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

29953311000001102: Accolate 20mg tablets (Lexon (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Aug 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
93574901000001116 Accolate 20mg tablets (Lexon (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
93575001000001116 Accolate 20mg tablets (Lexon (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Accolate 20mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) Is a Product containing precisely zafirlukast 20 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) Has active ingredient Zafirlukast false Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) Has specific active ingredient Zafirlukast true Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) Is a Accolate true Inferred relationship Existential restriction modifier
Accolate 20mg tablets (Lexon (UK) Ltd) VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Accolate 20mg tablets (Lexon (UK) Ltd) 56 tablet Has AMP True Accolate 20mg tablets (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start